Proteomics International Laboratories (ASX:PIQ) Net Margin % : -934.31% (As of Jun. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Proteomics International Laboratories Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Proteomics International Laboratories's Net Income for the six months ended in Jun. 2024 was A$-2.56 Mil. Proteomics International Laboratories's Revenue for the six months ended in Jun. 2024 was A$0.27 Mil. Therefore, Proteomics International Laboratories's net margin for the quarter that ended in Jun. 2024 was -934.31%.

The historical rank and industry rank for Proteomics International Laboratories's Net Margin % or its related term are showing as below:

ASX:PIQ' s Net Margin % Range Over the Past 10 Years
Min: -853.97 Med: -175.77 Max: -99.03
Current: -714.91

ASX:PIQ's Net Margin % is ranked worse than
69.5% of 1013 companies
in the Biotechnology industry
Industry Median: -140.3 vs ASX:PIQ: -714.91

Proteomics International Laboratories Net Margin % Historical Data

The historical data trend for Proteomics International Laboratories's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Proteomics International Laboratories Net Margin % Chart

Proteomics International Laboratories Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Net Margin %

Get a 7-Day Free Trial

-122.56

-218.15

-333.98

-853.97

-714.80

Proteomics International Laboratories Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Net Margin %	Get a 7-Day Free Trial														-214.83	-525.29	5,962.16	-617.64	-934.31

Competitive Comparison of Proteomics International Laboratories's Net Margin %

For the Biotechnology subindustry, Proteomics International Laboratories's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Proteomics International Laboratories's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Proteomics International Laboratories's Net Margin % distribution charts can be found below:

* The bar in red indicates where Proteomics International Laboratories's Net Margin % falls into.

Proteomics International Laboratories Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Proteomics International Laboratories's Net Margin for the fiscal year that ended in Jun. 2024 is calculated as

Net Margin	=	Net Income (A: Jun. 2024 )	/	Revenue (A: Jun. 2024 )
	=	-6.376	/	0.892
	=	-714.80 %

Proteomics International Laboratories's Net Margin for the quarter that ended in Jun. 2024 is calculated as

Net Margin	=	Net Income (Q: Jun. 2024 )	/	Revenue (Q: Jun. 2024 )
	=	-2.56	/	0.274
	=	-934.31 %

Proteomics International Laboratories (ASX:PIQ) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Proteomics International Laboratories Net Margin % Related Terms

Thank you for viewing the detailed overview of Proteomics International Laboratories's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Proteomics International Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Proteomics International Laboratories Ltd (ASX:PIQ) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

6 Verdun Street, QEII Medical Centre, QQ Block, Nedlands, Perth, WA, AUS, 6009

Website

https://www.proteomics.com.au

Proteomics International Laboratories Ltd is a biological research and drug discovery company. The company specializes in the area of proteomics which is the industrial-scale study of the structure and function of proteins. Its operations are divided into PromarkerD which targets the diabetes epidemic and is a predictive diagnostic test for diabetic kidney disease, a progressive disorder found in one in three adults with diabetes; its proprietary biomarker discovery platform called Promarker, which searches for protein fingerprints in a sample; and Analytical Services that are specialist contract research focusing on biosimilars quality control and pharmacokinetic testing for clinical trials.

Proteomics International Laboratories Headlines

No Headlines